-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12,000.00444344.44% Upside
Akari Therapeutics, Plc Frequently Asked Questions
-
What analysts cover Akari Therapeutics, Plc?
Akari Therapeutics, Plc has been rated by research analysts at H.C. Wainwright in the past 90 days.